A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive TP53-mutant Ovarian Cancer

Oza, Amit M.; Estevez-Diz, Maria; Grischke, Eva-Maria; Hall, Marcia; Marme, Frederik; Provencher, Diane; Uyar, Denise; Weberpals, Johanne I.; Wenham, Robert M.; Laing, Naomi; Tracy, Michael; Freshwater, Tomoko; Lee, Mark A.; Liu, Ji; Qiu, Jingjun; Rose, Shelonitda; Rubin, Eric H.; Moore, Kathleen

dc.contributor.author	Grischke, Eva-Maria
dc.date.accessioned	2021-07-19T08:49:08Z
dc.date.available	2021-07-19T08:49:08Z
dc.date.issued	2020
dc.identifier.issn	1557-3265
dc.identifier.uri	http://hdl.handle.net/10900/117142
dc.language.iso	en	de_DE
dc.publisher	Amer Assoc Cancer Research	de_DE
dc.relation.uri	http://dx.doi.org/10.1158/1078-0432.CCR-20-0219	de_DE
dc.subject.ddc	610	de_DE
dc.title	A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive TP53-mutant Ovarian Cancer	de_DE
dc.type	Article	de_DE
dc.type	ConferenceObject	de_DE
utue.quellen.id	20210304112512_01503
utue.publikation.seiten	4767-4776	de_DE
utue.personen.roh	Oza, Amit M.
utue.personen.roh	Estevez-Diz, Maria
utue.personen.roh	Grischke, Eva-Maria
utue.personen.roh	Hall, Marcia
utue.personen.roh	Marme, Frederik
utue.personen.roh	Provencher, Diane
utue.personen.roh	Uyar, Denise
utue.personen.roh	Weberpals, Johanne I.
utue.personen.roh	Wenham, Robert M.
utue.personen.roh	Laing, Naomi
utue.personen.roh	Tracy, Michael
utue.personen.roh	Freshwater, Tomoko
utue.personen.roh	Lee, Mark A.
utue.personen.roh	Liu, Ji
utue.personen.roh	Qiu, Jingjun
utue.personen.roh	Rose, Shelonitda
utue.personen.roh	Rubin, Eric H.
utue.personen.roh	Moore, Kathleen
dcterms.isPartOf.ZSTitelID	Clinical Cancer Research	de_DE
dcterms.isPartOf.ZS-Issue	18	de_DE
dcterms.isPartOf.ZS-Volume	26	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE